This content is machine translated Hematology New possibilities thanks to targeted therapy At the DGHO congress in Vienna, the focus was on new targeted therapies designed to improve the quality of life of patients with malignant hematologic diseases. In particular, medical advances…
View Post 6 min This content is machine translated 5th Interdisciplinary Prostate Cancer Symposium Metastatic prostate cancer – New therapeutic options Prostate cancer is the most common male tumor in Western countries and is the second leading cause of cancer-related death in Switzerland. In particular, metastatic castration-resistant prostate cancer (mCRPC) is…
View Post 1 min This content is machine translated Metastatic colorectal carcinoma Determination of mutational RAS status is important in mCRC The results of the FIRE-3 study, presented at this year’s European Cancer Congress in Amsterdam, emphasize the importance and relevance of RAS mutation analysis (KRAS and NRAS) for first-line treatment…
View Post 11 min This content is machine translated Stop smoking Information for daily practice It is undisputed that smoking is harmful and among the most important causes of premature morbidity and mortality. Because of the serious health consequences, smoking cessation counseling is important and…
View Post 9 min This content is machine translated Benign prostatic hyperplasia Comparison of different therapy methods While a great many 60- to 80-year-olds have prostatic hyperplasia, only about 40% of them show symptoms that include obstructive and irritative micturition symptoms. The following article discusses which examinations…
View Post 6 min This content is machine translated Sport and fatigue in cancer Sports therapy as a component of inpatient oncological rehabilitation More than 10 years ago, studies were already able to demonstrate the positive effect of endurance and strength training on fatigue symptoms in cancer patients. Since then, there have been…
View Post 5 min This content is machine translated Follow-up of curatively operated NSCLC. Many questions are still open Lung cancer is the most common fatal cancer worldwide, and its incidence is still increasing in modern times. Despite advances in diagnosis and treatment, the lethality of lung cancer leads…
View Post 12 min This content is machine translated Non-small cell lung cancer Individualized, palliative first-line therapy is possible Therapy for non-small cell lung cancer is individualized and based on tumor stage, histology, and predictive molecular markers, taking into account the patient profile. To maximize the therapeutic outcome for…
View Post 3 min This content is machine translated College breast cancer Seal for high-quality and practice-oriented training for five years now Under the label Kollegium Brustkrebs, a continuing education platform for specialists interested in breast cancer was created in 2008. The platform is characterized by a high level of quality and…
View Post 6 min This content is machine translated Suspicion of lung carcinoma Silent preclinical lung findings complicate diagnosis Lung carcinoma usually presents to the general practitioner as advanced disease with mostly nonspecific symptoms: As a silent preclinical lung finding, it must be specifically sought. Knowledge of the clinical…
View Post 2 min This content is machine translated Bronchus carcinoma Dawn in non-small cell lung cancer? At the beginning of every medical advance is the intention and hope of the researcher to understand a problem in order to then bring it to a solution. Hope is…
